2009
Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial
Diniz J, Shavitt R, Pereira C, Hounie A, Pimentel I, Koran L, Dainesi S, Miguel E. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. Journal Of Psychopharmacology 2009, 24: 297-307. PMID: 19164490, DOI: 10.1177/0269881108099423.Peer-Reviewed Original Research
2006
Clinical features associated to refractory obsessive–compulsive disorder
Ferrão Y, Shavitt R, Bedin N, de Mathis M, Lopes A, Fontenelle L, Torres A, Miguel E. Clinical features associated to refractory obsessive–compulsive disorder. Journal Of Affective Disorders 2006, 94: 199-209. PMID: 16764938, DOI: 10.1016/j.jad.2006.04.019.Peer-Reviewed Original ResearchAdultBrazilCase-Control StudiesChronic DiseaseCodependency, PsychologicalCognitive Behavioral TherapyCombined Modality TherapyComorbidityElectroconvulsive TherapyFemaleHospitalizationHumansMaleMental DisordersMiddle AgedObsessive-Compulsive DisorderQuality of LifeSelective Serotonin Reuptake InhibitorsSocioeconomic FactorsTreatment Failure